Microsoft has filed an amicus brief in support of Anthropic's lawsuit against the Department of Defense. The suit calls for the court to issue a temporary restraining order against the Pentagon's ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

The Pacific Northwest’s only commercial nuclear power plant was reconnected to the electric grid Tuesday afternoon and had ramped up to full power by Wednesday. Energy Northwest’s Columbia Generating ...

The Northwest’s only commercial nuclear power plant, the Columbia Generating Station, was manually shut down early Thursday morning due to a mechanical problem. Energy Northwest workers shut the plant ...

Gen Z, this will smart. The generation born between 1997 and 2010 is the very first generation who did worse in school than the generation before them, according to a top neuroscientist. And ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...

Adobe has been aggressively adding AI features to all its products in the last few years. The company is now adding more AI tools to Acrobat, including the ability to generate podcast summaries of ...

Elon Musk was forced to put restrictions on X and its AI chatbot, Grok, after its image generator sparked outrage around the world. Grok created non-consensual sexualized images, prompting some ...

Veradermics Inc. filed for an initial public offering to help commercialize its hair re-growth pill. Led by dermatologist co-founders Reid Waldman and Tim Durso, Veradermics is developing an oral, non ...